These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 31161804)

  • 1. The nonepigenetic role for small molecule histone deacetylase inhibitors in the regulation of cardiac function.
    Romanick SS; Ferguson BS
    Future Med Chem; 2019 Jun; 11(11):1345-1356. PubMed ID: 31161804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart.
    Habibian J; Ferguson BS
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure.
    Evans LW; Ferguson BS
    Nutrients; 2018 Aug; 10(8):. PubMed ID: 30126190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylases in modulating cardiac disease and their clinical translational and therapeutic implications.
    Wang Z; Zhao YT; Zhao TC
    Exp Biol Med (Maywood); 2021 Jan; 246(2):213-225. PubMed ID: 32727215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.
    Schuetze KB; McKinsey TA; Long CS
    J Mol Cell Cardiol; 2014 May; 70():100-7. PubMed ID: 24631770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential for HDAC inhibitors in the heart.
    McKinsey TA
    Annu Rev Pharmacol Toxicol; 2012; 52():303-19. PubMed ID: 21942627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
    Simon RP; Robaa D; Alhalabi Z; Sippl W; Jung M
    J Med Chem; 2016 Feb; 59(4):1249-70. PubMed ID: 26701186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting histone deacetylases for heart diseases.
    Jin G; Wang K; Zhao Y; Yuan S; He Z; Zhang J
    Bioorg Chem; 2023 Sep; 138():106601. PubMed ID: 37224740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of histone deacetylases.
    Huang Y; Shaw PG; Davidson NE
    Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
    Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
    Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical and structural biology of protein lysine deacetylases.
    Yoshida M; Kudo N; Kosono S; Ito A
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(5):297-321. PubMed ID: 28496053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin modifications remodel cardiac gene expression.
    Mathiyalagan P; Keating ST; Du XJ; El-Osta A
    Cardiovasc Res; 2014 Jul; 103(1):7-16. PubMed ID: 24812277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of histone deacetylases in bone development and skeletal disorders.
    Wang JS; Yoon SH; Wein MN
    Bone; 2021 Feb; 143():115606. PubMed ID: 32829038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel class of small molecule inhibitors of HDAC6.
    Inks ES; Josey BJ; Jesinkey SR; Chou CJ
    ACS Chem Biol; 2012 Feb; 7(2):331-9. PubMed ID: 22047054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of dietary histone deacetylases (HDACs) inhibitors in health and disease.
    Bassett SA; Barnett MP
    Nutrients; 2014 Oct; 6(10):4273-301. PubMed ID: 25322459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting histone deacetylases: development of vorinostat for the treatment of cancer.
    Richon VM
    Epigenomics; 2010 Jun; 2(3):457-65. PubMed ID: 22121904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biology and therapeutic implications of HDACs in the heart.
    McKinsey TA
    Handb Exp Pharmacol; 2011; 206():57-78. PubMed ID: 21879446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors in the treatment for multiple myeloma.
    Hideshima T; Anderson KC
    Int J Hematol; 2013 Mar; 97(3):324-32. PubMed ID: 23475757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors.
    Bush EW; McKinsey TA
    Circ Res; 2010 Feb; 106(2):272-84. PubMed ID: 20133912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibitors of zinc-dependent histone deacetylases.
    Wagner FF; WeŃ—wer M; Lewis MC; Holson EB
    Neurotherapeutics; 2013 Oct; 10(4):589-604. PubMed ID: 24101253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.